Over time, the GLP-1 population has evolved to include an increasing prevalence of patients with no prior antidiabetic prescriptions and with fewer diabetes diagnoses
Common ZEPBOUND side effects include nausea, diarrhea, vomiting, constipation, abdominal pain, indigestion, injection site reactions, fatigue, allergic responses, belching, hair loss, and heartburn, though this is not an exhaustive list of potential ZEPBOUND side effects
The resulting elimination half-life of approximately 13 h supports a once-daily dosing regimen [19]
An increase in the diagnosis of HFpEF was noted in both sexes [3, 4]
Research peptides in pharma-grade quality For research applications, peptide purity is essential for reliable results
Most effective when combined with adequate hydration